Oligonucleotide Services
Choose excellence, choose WuXi Biology- your reliable partner in oligonucleotide drug discovery. WuXi Biology provides an integrated service platform for support of the discovery of oligonucleotide drugs. Our services cover sequence and modification design of oligonucleotides, in vitro and in vivo biological and PK/PD evaluations, and assessment of oligonucleotide off-target effects. Our broad and deep expertise spans cross diverse oligonucleotide modalities, including siRNAs, Gapmers ASOs, splicing-switch ASOs and mRNAs. We have supported multiple projects for oligonucleotide drug discovery as well as more than 14 IND projects since 2021.
View our platform of oligonucleotide services by clicking HERE.
Oligonucleotide_Platform
Related Content
Unlike conventional protein-targeted therapies, nucleic acid therapeutics have the potential for long-lasting effects and greater target specificity. WuXi AppTec provides...
VIEW RESOURCERNA interference using small interfering RNA (siRNA) molecules has emerged as a promising therapeutic modality. To accelerate the discovery of...
VIEW RESOURCE